Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome

Cell

Volumn 160, Issue 1-2, 2015, Pages 62-73

  Yan, Yiqing ^a   Jiang, Wei ^a   Liu, Lei ^a   Wang, Xiaqiong ^a   Ding, Chen ^c   Tian, Zhigang ^a,b   Zhou, Rongbin ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c BEIJING INSTITUTE OF LIFEOMICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN; CRYOPYRIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; FORSKOLIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; NIGERICIN; UBIQUITIN PROTEIN LIGASE E3; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; DOPAMINE RECEPTOR; DRD1 PROTEIN, HUMAN; PROTEIN AGGREGATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BONE MARROW DERIVED MACROPHAGE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOPAMINERGIC NERVE CELL; INFLAMMATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYSTEMIC DISEASE; UBIQUITINATION; WILD TYPE; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; CARRIER PROTEINS; CYCLIC AMP; DOPAMINE; INFLAMMASOMES; INFLAMMATION; MICE; MICE, INBRED C57BL; NEUROTRANSMITTER AGENTS; PROTEIN AGGREGATES; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84920990887     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2014.11.047     Document Type: Article

References (48)

1. S. Alfonso-Loeches, J.R. Ureña-Peralta, M.J. Morillo-Bargues, J. Oliver-De La Cruz, and C. Guerri Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells Front. Cell. Neurosci. 8 2014 216
2. S. Basu, and P.S. Dasgupta Dopamine, a neurotransmitter, influences the immune system J. Neuroimmunol. 102 2000 113 124
3. S. Basu, J.A. Nagy, S. Pal, E. Vasile, I.A. Eckelhoefer, V.S. Bliss, E.J. Manseau, P.S. Dasgupta, H.F. Dvorak, and D. Mukhopadhyay The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor Nat. Med. 7 2001 569 574
4. F.G. Bauernfeind, G. Horvath, A. Stutz, E.S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. Wu, B.G. Monks, and K.A. Fitzgerald Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression J. Immunol. 183 2009 787 791
5. F. Bauernfeind, A. Ablasser, E. Bartok, S. Kim, J. Schmid-Burgk, T. Cavlar, and V. Hornung Inflammasomes: current understanding and open questions Cell. Mol. Life Sci. 68 2011 765 783
6. J.M. Beaulieu, and R.R. Gainetdinov The physiology, signaling, and pharmacology of dopamine receptors Pharmacol. Rev. 63 2011 182 217
7. J.M. Beaulieu, T.D. Sotnikova, W.D. Yao, L. Kockeritz, J.R. Woodgett, R.R. Gainetdinov, and M.G. Caron Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc. Natl. Acad. Sci. USA 101 2004 5099 5104
8. G.Ch. Beck, P. Brinkkoetter, C. Hanusch, J. Schulte, K. van Ackern, F.J. van der Woude, and B.A. Yard Clinical review: immunomodulatory effects of dopamine in general inflammation Crit. Care 8 2004 485 491
9. J. Bergquist, A. Tarkowski, R. Ekman, and A. Ewing Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop Proc. Natl. Acad. Sci. USA 91 1994 12912 12916
10. V. Brochard, B. Combadière, A. Prigent, Y. Laouar, A. Perrin, V. Beray-Berthat, O. Bonduelle, D. Alvarez-Fischer, J. Callebert, and J.M. Launay Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease J. Clin. Invest. 119 2009 182 192
11. D. Chakroborty, U.R. Chowdhury, C. Sarkar, R. Baral, P.S. Dasgupta, and S. Basu Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization J. Clin. Invest. 118 2008 1380 1389
12. G. Codolo, N. Plotegher, T. Pozzobon, M. Brucale, I. Tessari, L. Bubacco, and M. de Bernard Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies PLoS ONE 8 2013 e55375
13. B.K. Davis, H. Wen, and J.P. Ting The inflammasome NLRs in immunity, inflammation, and associated diseases Annu. Rev. Immunol. 29 2011 707 735
14. D. De Backer, P. Biston, J. Devriendt, C. Madl, D. Chochrad, C. Aldecoa, A. Brasseur, P. Defrance, P. Gottignies, J.L. Vincent SOAP II Investigators Comparison of dopamine and norepinephrine in the treatment of shock N. Engl. J. Med. 362 2010 779 789
15. J. Drago, C.R. Gerfen, J.E. Lachowicz, H. Steiner, T.R. Hollon, P.E. Love, G.T. Ooi, A. Grinberg, E.J. Lee, and S.P. Huang Altered striatal function in a mutant mouse lacking D1A dopamine receptors Proc. Natl. Acad. Sci. USA 91 1994 12564 12568
16. L. Franchi, T. Eigenbrod, and G. Núñez Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation J. Immunol. 183 2009 792 796
17. M.C. Ghosh, A.C. Mondal, S. Basu, S. Banerjee, J. Majumder, D. Bhattacharya, and P.S. Dasgupta Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells Int. Immunopharmacol. 3 2003 1019 1026
18. M. Gloerich, and J.L. Bos Epac: defining a new mechanism for cAMP action Annu. Rev. Pharmacol. Toxicol. 50 2010 355 375
19. G. Guarda, M. Braun, F. Staehli, A. Tardivel, C. Mattmann, I. Förster, M. Farlik, T. Decker, R.A. Du Pasquier, P. Romero, and J. Tschopp Type I interferon inhibits interleukin-1 production and inflammasome activation Immunity 34 2011 213 223
20. A. Halle, V. Hornung, G.C. Petzold, C.R. Stewart, B.G. Monks, T. Reinheckel, K.A. Fitzgerald, E. Latz, K.J. Moore, and D.T. Golenbock The NALP3 inflammasome is involved in the innate immune response to amyloid-beta Nat. Immunol. 9 2008 857 865
21. E. Josefsson, J. Bergquist, R. Ekman, and A. Tarkowski Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis Immunology 88 1996 140 146
22. C. Juliana, T. Fernandes-Alnemri, S. Kang, A. Farias, F. Qin, and E.S. Alnemri Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation J. Biol. Chem. 287 2012 36617 36622
23. M.A. Kelly, M. Rubinstein, S.L. Asa, G. Zhang, C. Saez, J.R. Bunzow, R.G. Allen, R. Hnasko, N. Ben-Jonathan, D.K. Grandy, and M.J. Low Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice Neuron 19 1997 103 113
24. M. Lamkanfi, and V.M. Dixit Inflammasomes and their roles in health and disease Annu. Rev. Cell Dev. Biol. 28 2012 137 161
25. G.S. Lee, N. Subramanian, A.I. Kim, I. Aksentijevich, R. Goldbach-Mansky, D.B. Sacks, R.N. Germain, D.L. Kastner, and J.J. Chae The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP Nature 492 2012 123 127
26. K.M. Lucin, and T. Wyss-Coray Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64 2009 110 122
27. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 2006 237 241
28. F. Martinon, A. Mayor, and J. Tschopp The inflammasomes: guardians of the body Annu. Rev. Immunol. 27 2009 229 265
29. F. McKenna, P.J. McLaughlin, B.J. Lewis, G.C. Sibbring, J.A. Cummerson, D. Bowen-Jones, and R.J. Moots Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study J. Neuroimmunol. 132 2002 34 40
30. E.J. Meredith, A. Chamba, M.J. Holder, N.M. Barnes, and J. Gordon Close encounters of the monoamine kind: immune cells betray their nervous disposition Immunology 115 2005 289 295
31. B.B. Mishra, V.A. Rathinam, G.W. Martens, A.J. Martinot, H. Kornfeld, K.A. Fitzgerald, and C.M. Sassetti Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β Nat. Immunol. 14 2013 52 60
32. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Dopamine receptors: from structure to function Physiol. Rev. 78 1998 189 225
33. A. Nishi, M. Kuroiwa, and T. Shuto Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons Front. Neuroanat. 5 2011 43
34. P.S. Olofsson, M. Rosas-Ballina, Y.A. Levine, and K.J. Tracey Rethinking inflammation: neural circuits in the regulation of immunity Immunol. Rev. 248 2012 188 204
35. V.H. Perry Innate inflammation in Parkinson's disease Cold Spring Harb. Perspect. Med. 2 2012 a009373
36. B.F. Py, M.S. Kim, H. Vakifahmetoglu-Norberg, and J. Yuan Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity Mol. Cell 49 2013 331 338
37. A. Ricci, E. Bronzetti, F. Mignini, S.K. Tayebati, D. Zaccheo, and F. Amenta Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes J. Neuroimmunol. 96 1999 234 240
38. M.C. Rodrigues, P.R. Sanberg, L.E. Cruz, and S. Garbuzova-Davis The innate and adaptive immunological aspects in neurodegenerative diseases J. Neuroimmunol. 269 2013 1 8
39. F. Rouge-Pont, A. Usiello, M. Benoit-Marand, F. Gonon, P.V. Piazza, and E. Borrelli Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors J. Neurosci. 22 2002 3293 3301
40. C. Sarkar, B. Basu, D. Chakroborty, P.S. Dasgupta, and S. Basu The immunoregulatory role of dopamine: an update Brain Behav. Immun. 24 2010 525 528
41. J. Saura, J.M. Tusell, and J. Serratosa High-yield isolation of murine microglia by mild trypsinization Glia 44 2003 183 189
42. K. Schroder, and J. Tschopp The inflammasomes Cell 140 2010 821 832
43. W. Shao, S.Z. Zhang, M. Tang, X.H. Zhang, Z. Zhou, Y.Q. Yin, Q.B. Zhou, Y.Y. Huang, Y.J. Liu, and E. Wawrousek Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin Nature 494 2013 90 94
44. R. Torres-Rosas, G. Yehia, G. Peña, P. Mishra, M. del Rocio Thompson-Bonilla, M.A. Moreno-Eutimio, L.A. Arriaga-Pizano, A. Isibasi, and L. Ulloa Dopamine mediates vagal modulation of the immune system by electroacupuncture Nat. Med. 20 2014 291 295
45. K.J. Tracey Reflex control of immunity Nat. Rev. Immunol. 9 2009 418 428
46. U. Wüllner, and T. Klockgether Inflammation in Parkinson's disease J. Neurol. 250 Suppl 1 2003 I35 I38
47. Y. Yan, W. Jiang, T. Spinetti, A. Tardivel, R. Castillo, C. Bourquin, G. Guarda, Z. Tian, J. Tschopp, and R. Zhou Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation Immunity 38 2013 1154 1163
48. M.B. Youdim, D. Edmondson, and K.F. Tipton The therapeutic potential of monoamine oxidase inhibitors Nat. Rev. Neurosci. 7 2006 295 309